These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26573621)

  • 1. Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe.
    Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; Spapen HD
    Crit Care; 2015 Nov; 19():392. PubMed ID: 26573621
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!
    Honore PM; Spapen HD
    Crit Care; 2016 Apr; 20():87. PubMed ID: 27044560
    [No Abstract]   [Full Text] [Related]  

  • 3. Dialysis with high-flux membranes significantly affects plasma levels of neutrophil gelatinase-associated lipocalin.
    Donadio C
    Crit Care; 2016 Jan; 20():20. PubMed ID: 26826870
    [No Abstract]   [Full Text] [Related]  

  • 4. Early detection of acute kidney injury with neutrophil gelatinase-associated lipocalin.
    McCullough PA; El-Ghoroury M; Yamasaki H
    J Am Coll Cardiol; 2011 Apr; 57(17):1762-4. PubMed ID: 21511112
    [No Abstract]   [Full Text] [Related]  

  • 5. The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied.
    Schilder L; Nurmohamed SA; ter Wee PM; Paauw NJ; Girbes AR; Beishuizen A; Beelen RH; Groeneveld AB
    Crit Care; 2014 Apr; 18(2):R78. PubMed ID: 24755339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
    Ostermann M; Forni LG
    Crit Care; 2014 Jun; 18(3):155. PubMed ID: 25042547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
    Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
    Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*.
    Ricci Z; Netto R; Garisto C; Iacoella C; Favia I; Cogo P
    Pediatr Crit Care Med; 2012 Nov; 13(6):667-70. PubMed ID: 22895007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous renal replacement therapy in critically ill patients does not affect urinary neutrophil gelatinase-associated lipocalin levels.
    Vasileiadis I; Pipili C; Nanas S
    Crit Care; 2015 Mar; 19(1):140. PubMed ID: 25887059
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential role of neutrophil gelatinase-associated lipocalin in identifying critically ill patients with acute kidney injury stage 2-3 who subsequently require renal replacement therapy.
    Tiranathanagul K; Amornsuntorn S; Avihingsanon Y; Srisawat N; Susantitaphong P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Ther Apher Dial; 2013 Jun; 17(3):332-8. PubMed ID: 23735150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it the neutrophil gelatinase-associated lipocalin or the pediatricRIFLE?*.
    Daniels RC; Bunchman TE
    Pediatr Crit Care Med; 2012 Nov; 13(6):698. PubMed ID: 23128593
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Renal Injury Following Extracorporeal Membrane Oxygenation.
    Zwiers AJ; Cransberg K; de Rijke YB; van Rosmalen J; Tibboel D; de Wildt SN
    Pediatr Crit Care Med; 2015 Sep; 16(7):663-70. PubMed ID: 26121099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for early acute kidney injury.
    Shemin D; Dworkin LD
    Crit Care Clin; 2011 Apr; 27(2):379-89. PubMed ID: 21440207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin as a predictor of adverse renal outcomes in immunoglobulin A nephropathy.
    Ma SK
    Korean J Intern Med; 2015 May; 30(3):305-7. PubMed ID: 25995660
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis.
    Hjortrup PB; Haase N; Treschow F; Møller MH; Perner A
    Acta Anaesthesiol Scand; 2015 Jan; 59(1):25-34. PubMed ID: 25363361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients.
    de Geus HR; Betjes MG; Bakker J
    Intensive Care Med; 2010 Dec; 36(12):2156-7. PubMed ID: 20721534
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutrophil gelatinase-associated lipocalin: a novel biomarker in acute kidney injury.
    Carrillo-Esper R; Castillo-Albarrán FM; Pérez-Jáuregui J
    Cir Cir; 2011; 79(6):577-81. PubMed ID: 22169379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute kidney injury: new insights from diagnostics and treatment].
    Bienholz A; Kribben A; Feldkamp T
    Dtsch Med Wochenschr; 2012 Mar; 137(13):652-5. PubMed ID: 22434174
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neutrophil gelatinase-associated lipocalin (NGAL): a biomarker beyond the confines of nephrology].
    Bolignano D
    G Ital Nefrol; 2010; 27(1):6. PubMed ID: 20191452
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomarkers for acute kidney injury: is NGAL ready for clinical use?
    Ronco C
    Crit Care; 2014 Dec; 18(6):680. PubMed ID: 25672254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.